U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541833) titled 'Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)' on March 11.
Brief Summary: The purpose of this study is to assess the real-world effectiveness and safety of mavacamten in adults diagnosed with symptomatic obstructive hypertrophic cardiomyopathy (HOCM) receiving cibenzoline in Japan
Study Start Date: Feb. 05
Study Type: OBSERVATIONAL
Condition:
Cardiomyopathy
Intervention:
DRUG: Mavacamten
According to the product label
Recruitment Status: RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital Content Services with permission from...